Bowel Preparation for Colonoscopy Clinical Trial
Official title:
Multidisciplinary Approach Versus Conventional Approach in Colonic Preparation of Hospitalized Patients. A Randomized Controlled Trial
Colonoscopy is the gold standard diagnostic procedure for colonic disease. Excellent bowel
cleansing is critical for this procedure. However, an inadequate bowel cleansing is a common
problem that occurs up to 20% of procedures. This fact has a deep clinical and economical
impact. In fact, inadequate bowel preparation is associated to misdiagnosis in 30% of
lesions. Moreover several clinical conditions such as cirrhosis, antidepressant drugs, and
hospitalized patients are predictive factors of inadequate colonic preparations. These
circumstances have promoted multiple clinical trials, however there is no consensus about
the optimal strategy for colonic cleansing. Education in colonic preparation has obtained
conflicting results. Polyethylene glycol (PEG) and sodium phosphate solutions have been the
commonest preparations used with a similar efficacy. However, the large volume to ingest (4
litters) makes PEG compliance difficult. Likewise, sodium phosphate also contains high
levels in sodium and phosphate which contraindicate its use in elderly patients and / or
with comorbidity. The use of adjuvants such as olive oil and bisacodyl allows reducing the
volume of polyethylene glycol thereby improving the tolerance and right colon preparation.
The aim of this study is to compare the efficacy of a multidisciplinary approach (education,
fiber free diet, polyethylene glycol (PEG) 2L, and adjuvant bisacodyl + olive oil) vs. a
conventional approach (fiber free diet+ PEG 4L in split doses ) in cleaning the colon of
hospitalized patients.
| Status | Not yet recruiting |
| Enrollment | 162 |
| Est. completion date | December 2013 |
| Est. primary completion date | December 2013 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Hospitalized patients who undergo a non urgent colonoscopy - Patients who give informed consent to participate in the study - Patients older than 18 years - Patients who undergo total colonoscopy Exclusion Criteria: - Non compliance with the 48 hours diet prescribed - The endoscopy planned is a rectosigmoidoscopy - Previous colonic surgery - Mental/cognitive impairment preventing the study assessments - Severe renal failure - Electrolytic disbalance(hyponatremia, hypokaliemia, Hyperphosphatemia, hypocalcemia and hypomagnesemia) - Intestinal obstruction, perforation or toxic megacolon - Pregnant or nursing women - Allergy/intolerance to PEG, bisacodyl or adjuvants - No informed consent |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Spain | Hospital de Sabadell | Sabadell | Barcelona |
| Lead Sponsor | Collaborator |
|---|---|
| Corporacion Parc Tauli |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | percentage of patients with adequate bowel preparation | Adequate bowel preparation is defined as a preparation which allows exploring the whole colonic mucose and detecting flat lesions (Rating as good or excellent in the Boston Bowel preparation scale) | at the time of performing the colonoscopy | No |
| Secondary | Percentage of patients with adequate bowel preparation by bowel segments | The boston scale will be assessed by the investigators during the procedure. | At the time of performing the colonoscopy | No |
| Secondary | Tolerance to the colonoscopy | Tolerance to the colonoscopy will be measured by VAS during the colonoscopy, 30 minutes after colonoscopy and 24 hours after colonoscopy | from colonoscopy up to 24 hours after colonoscopy | Yes |
| Secondary | Percentage of complete/incomplete colonoscopies and reprogramming | Evaluation of incomplete or inadequate bowel preparation will be assessed after performing the colonoscopy | After the colonoscopy | No |
| Secondary | Complications during and after the procedure | up to 24 hours after colonoscopy | Yes | |
| Secondary | Doses of sedation needed during the colonoscopy | Final dose will be calculated at the end of the procedure | During the colonoscopy process | No |
| Secondary | Tolerance to the preparation | up to 48 hours | Yes | |
| Secondary | Endoscopic findings | during the colonoscopy | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02839824 -
Evaluation of the Quality of Bowel Cleansing in a Real Clinical Practice Setting
|
N/A | |
| Completed |
NCT01719653 -
A Comparison of 5 Low Volume Bowel Preparations
|
Phase 4 | |
| Completed |
NCT01929590 -
Low-volume Polyethylene Glycol Bowel Preparation for Colonoscopy
|
Phase 3 | |
| Completed |
NCT00611442 -
Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy
|
N/A | |
| Recruiting |
NCT01028573 -
A Study Comparing PEG-3350 (Miralax) and Gatorade With PEG-ELS (Golytely) for Bowel Preparation Prior to Colonoscopy
|
N/A | |
| Completed |
NCT05291325 -
Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy
|
N/A | |
| Completed |
NCT01415687 -
Split Dose Pico-Salax + Bisacodyl vs. PEG Split Dose
|
Phase 3 | |
| Completed |
NCT05465889 -
Efficacy and Safety of Oral Sulfate Solution on Bowel Preparation for Colonoscopy
|
Phase 3 | |
| Completed |
NCT03055689 -
Bowel Preparation for Repeat Colonoscopy After Preparation Failure (RepeatPrep Study)
|
N/A | |
| Completed |
NCT02376465 -
A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy
|
Phase 2 | |
| Completed |
NCT01765491 -
Comparison of Two Methods of Bowel Preparation for Colonoscopy in Hospitalized Patients
|
N/A |